Chief Financial Officer

• 2017 - Present

Clinical stage company advancing a small molecule platelet receptor antagonist. Clinical stage company advancing a small molecule platelet receptor antagonist.

Consultant

• 2012 - Present

Provide consulting services to life science organizations in various stages including clinical stage, development stage, and formation/start up. Roles have ranged from assisting a public company meet reporting deadlines to establishing banking, IT infrastructure, and financial systems for a formation stage company. Efficient, organized and adaptable services provided in all aspects of finance and accounting including forecasting and budgeting, cash management, clinical trial accounting,… Show more Provide consulting services to life science organizations in various stages including clinical stage, development stage, and formation/start up. Roles have ranged from assisting a public company meet reporting deadlines to establishing banking, IT infrastructure, and financial systems for a formation stage company. Efficient, organized and adaptable services provided in all aspects of finance and accounting including forecasting and budgeting, cash management, clinical trial accounting, stock option administration, retirement plan selection, implementation and administration, audit and tax preparation and management, GAAP interpretation and compliance. Show less Provide consulting services to life science organizations in various stages including clinical stage, development stage, and formation/start up. Roles have ranged from assisting a public company meet reporting deadlines to establishing banking, IT infrastructure, and financial systems for a formation stage company. Efficient, organized and adaptable services provided in all aspects of finance and accounting including forecasting and budgeting, cash management, clinical trial accounting,… Show more Provide consulting services to life science organizations in various stages including clinical stage, development stage, and formation/start up. Roles have ranged from assisting a public company meet reporting deadlines to establishing banking, IT infrastructure, and financial systems for a formation stage company. Efficient, organized and adaptable services provided in all aspects of finance and accounting including forecasting and budgeting, cash management, clinical trial accounting, stock option administration, retirement plan selection, implementation and administration, audit and tax preparation and management, GAAP interpretation and compliance. Show less

Sr. Director, Finance / Consultant

• 2018 - 2020

Consultant

• 2016 - 2017

Clinical trial unit with public sector and private sector trial sponsors. Clinical trial unit with public sector and private sector trial sponsors.

Consultant

• 2015 - 2016

Financial Consultant

• 2015 - 2016

Acquired by ContraVir Pharmaceuticals/Hepion Pharmaceuticals in 2016. Acquired by ContraVir Pharmaceuticals/Hepion Pharmaceuticals in 2016.

Senior Director, Finance

• 2013 - 2013

In 2013 AnaptysBio was a privately held, preclinical stage, antibody development company advancing first-in-class programs in inflammation and immuno-oncology. Reported to CEO. Resigned due to family relocation to East Coast. In 2013 AnaptysBio was a privately held, preclinical stage, antibody development company advancing first-in-class programs in inflammation and immuno-oncology. Reported to CEO. Resigned due to family relocation to East Coast.

Financial Consultant

• 2012 - 2013

Pre-clinical company focused on solving the problem of targeting and delivery of nucleic acid therapeutics. Reported to CSO/Founder. Pre-clinical company focused on solving the problem of targeting and delivery of nucleic acid therapeutics. Reported to CSO/Founder.

Senior Director, Finance

• 2007 - 2011

Clinical stage biopharmaceutical company committed to the development and commercialization of immunotherapies for the treatment of cancer, respiratory and inflammatory diseases. Reported to Chief Business Officer/Founder. Acquired by Celgene. Clinical stage biopharmaceutical company committed to the development and commercialization of immunotherapies for the treatment of cancer, respiratory and inflammatory diseases. Reported to Chief Business Officer/Founder. Acquired by Celgene.

Financial Consultant

• 2001 - 2005

Manager, Financial Utilization and Analysis

• 1995 - 1998

Manager

• 1991 - 1995